Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.070
-0.010 (-0.93%)
Dec 3, 2024, 1:27 PM EST - Market open
Artelo Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 4.36 | 2.82 | 6.89 | 12.16 | 6.63 | 2.14 | Upgrade
|
Short-Term Investments | - | - | 1.5 | - | - | - | Upgrade
|
Trading Asset Securities | 0.5 | 7.61 | 9.15 | 11.95 | 3.44 | - | Upgrade
|
Cash & Short-Term Investments | 4.86 | 10.43 | 17.53 | 24.11 | 10.07 | 2.14 | Upgrade
|
Cash Growth | -62.24% | -40.53% | -27.29% | 139.57% | 369.89% | -51.58% | Upgrade
|
Prepaid Expenses | 0.13 | 0.55 | 0.79 | 0.5 | 0.25 | 0.2 | Upgrade
|
Total Current Assets | 4.99 | 10.98 | 18.32 | 24.61 | 10.32 | 2.34 | Upgrade
|
Property, Plant & Equipment | 0.11 | 0.02 | 0.06 | 0.08 | 0.09 | - | Upgrade
|
Long-Term Investments | - | - | - | 1.52 | - | - | Upgrade
|
Other Intangible Assets | 2.04 | 2.04 | 2.04 | 2.04 | 2.04 | 2.04 | Upgrade
|
Other Long-Term Assets | 0 | 0 | 0 | 0 | 0.19 | - | Upgrade
|
Total Assets | 7.14 | 13.04 | 20.42 | 28.25 | 12.64 | 4.38 | Upgrade
|
Accounts Payable | 0.63 | 1.24 | 0.91 | 0.98 | 0.47 | 0.49 | Upgrade
|
Accrued Expenses | 0.04 | 0.03 | 0.05 | 0.02 | 0.01 | 0.01 | Upgrade
|
Current Portion of Leases | 0.03 | 0.02 | 0.04 | 0.03 | 0.03 | - | Upgrade
|
Other Current Liabilities | - | - | - | - | 0.02 | 0.01 | Upgrade
|
Total Current Liabilities | 0.7 | 1.29 | 1 | 1.03 | 0.53 | 0.5 | Upgrade
|
Long-Term Leases | 0.08 | - | 0.02 | 0.06 | 0.07 | - | Upgrade
|
Total Liabilities | 0.78 | 1.29 | 1.02 | 1.08 | 0.59 | 0.5 | Upgrade
|
Common Stock | 0 | 0 | 0 | 0 | 0 | 0.01 | Upgrade
|
Additional Paid-In Capital | 52.93 | 52.26 | 50.68 | 48.12 | 28.93 | 13.27 | Upgrade
|
Retained Earnings | -46.36 | -40.31 | -31.02 | -20.94 | -16.9 | -9.47 | Upgrade
|
Comprehensive Income & Other | -0.22 | -0.2 | -0.25 | -0.02 | 0.02 | 0.06 | Upgrade
|
Shareholders' Equity | 6.36 | 11.75 | 19.4 | 27.17 | 12.04 | 3.88 | Upgrade
|
Total Liabilities & Equity | 7.14 | 13.04 | 20.42 | 28.25 | 12.64 | 4.38 | Upgrade
|
Total Debt | 0.11 | 0.02 | 0.06 | 0.09 | 0.1 | - | Upgrade
|
Net Cash (Debt) | 4.75 | 10.4 | 17.47 | 24.03 | 9.97 | 2.14 | Upgrade
|
Net Cash Growth | -63.02% | -40.45% | -27.28% | 140.97% | 365.45% | -51.58% | Upgrade
|
Net Cash Per Share | 1.48 | 3.51 | 6.17 | 10.77 | 8.01 | 8.67 | Upgrade
|
Filing Date Shares Outstanding | 3.23 | 3.23 | 2.86 | 2.82 | 2.82 | 1.01 | Upgrade
|
Total Common Shares Outstanding | 3.23 | 3.19 | 2.86 | 2.82 | 1.64 | 0.33 | Upgrade
|
Working Capital | 4.29 | 9.69 | 17.32 | 23.58 | 9.79 | 1.84 | Upgrade
|
Book Value Per Share | 1.97 | 3.69 | 6.79 | 9.63 | 7.36 | 11.64 | Upgrade
|
Tangible Book Value | 4.32 | 9.71 | 17.36 | 25.13 | 10 | 1.84 | Upgrade
|
Tangible Book Value Per Share | 1.34 | 3.05 | 6.08 | 8.91 | 6.12 | 5.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.